Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew S Simms

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Nature Communications|March 29, 2013
Monoallelic expression of TMPRSS2/ERG in prostate cancer stem cellsEuan S Polson, John L Lewis, Hamza Celik, et al.
FEBS Letters|August 31, 2019
Notch signalling is a potential resistance mechanism of progenitor cells within patient-derived prostate cultures following ROS-inducing treatmentsJohn R Packer, Adam M Hirst, Alastair P Droop, et al.
European Urology|September 20, 2014
MicroRNA expression profile of primary prostate cancer stem cells as a source of biomarkers and therapeutic targetsJayant K Rane, Mauro Scaravilli, Antti Ylipää, et al.
European Urology Open Science|August 2, 2021
Overexpression of Placental Growth Factor in Stromal Cells from Benign Prostatic Hyperplasia: Another Piece in the Puzzle?Conor M Devlin, Fiona M Frame, Leanne K Archer, et al.
Oncotarget|September 17, 2017
Inhibition of the PI3K/AKT/mTOR pathway activates autophagy and compensatory Ras/Raf/MEK/ERK signalling in prostate cancerDominika E Butler, Christopher Marlein, Hannah F Walker, et al.
Plos One|May 16, 2013
Differential cytotoxic activity of a novel palladium-based compound on prostate cell lines, primary prostate epithelial cells and prostate stem cellsEngin Ulukaya, Fiona M Frame, Buse Cevatemre, et al.
Molecular Cancer|August 2, 2011
Regulation of the stem cell marker CD133 is independent of promoter hypermethylation in human epithelial differentiation and cancerDavide Pellacani, Richard J Packer, Fiona M Frame, et al.
FEBS Open Bio|April 26, 2022
ETS transcription factor ELF3 (ESE-1) is a cell cycle regulator in benign and malignant prostateLeanne K Archer, Fiona M Frame, Hannah F Walker, et al.
European Urology Oncology|June 4, 2019
Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectivenessBeth S Woods, Eleftherios Sideris, Matthew R Sydes, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Nature Communications|March 29, 2013
Monoallelic expression of TMPRSS2/ERG in prostate cancer stem cellsEuan S Polson, John L Lewis, Hamza Celik, et al.
FEBS Letters|August 31, 2019
Notch signalling is a potential resistance mechanism of progenitor cells within patient-derived prostate cultures following ROS-inducing treatmentsJohn R Packer, Adam M Hirst, Alastair P Droop, et al.
European Urology|September 20, 2014
MicroRNA expression profile of primary prostate cancer stem cells as a source of biomarkers and therapeutic targetsJayant K Rane, Mauro Scaravilli, Antti Ylipää, et al.
European Urology Open Science|August 2, 2021
Overexpression of Placental Growth Factor in Stromal Cells from Benign Prostatic Hyperplasia: Another Piece in the Puzzle?Conor M Devlin, Fiona M Frame, Leanne K Archer, et al.
Oncotarget|September 17, 2017
Inhibition of the PI3K/AKT/mTOR pathway activates autophagy and compensatory Ras/Raf/MEK/ERK signalling in prostate cancerDominika E Butler, Christopher Marlein, Hannah F Walker, et al.
Plos One|May 16, 2013
Differential cytotoxic activity of a novel palladium-based compound on prostate cell lines, primary prostate epithelial cells and prostate stem cellsEngin Ulukaya, Fiona M Frame, Buse Cevatemre, et al.
Molecular Cancer|August 2, 2011
Regulation of the stem cell marker CD133 is independent of promoter hypermethylation in human epithelial differentiation and cancerDavide Pellacani, Richard J Packer, Fiona M Frame, et al.
FEBS Open Bio|April 26, 2022
ETS transcription factor ELF3 (ESE-1) is a cell cycle regulator in benign and malignant prostateLeanne K Archer, Fiona M Frame, Hannah F Walker, et al.
European Urology Oncology|June 4, 2019
Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectivenessBeth S Woods, Eleftherios Sideris, Matthew R Sydes, et al.
Pageof 2